ARCHIVES

Drug Development Gets Extra $500,000

This article is from The Cancer Letter archive.

Vol. 03 No. 46 | November 18, 1977

Download PDF Visit The Full Archive

Related Articles

No Difference in Toxicity Between IMRT and PRT In Medicare Patients

January 25, 2013

Burzynski, Monaco Clashed In Court

June 5, 1992

Full Text Of NCI-Specific Language In House Report

July 31, 1992

House Members Form Group To Address Cancer Policy.

February 23, 2001

Biological Modifiers Journal Objects To NEJ Policy, Says It Will OK Clinical Data Release

April 26, 1985

AACR thanks NCI for funds, provides platform for von Eschenbach’s 2015 goal. Also 2015 goal not a dream, but a vision, NCI director says.

July 18, 2003